Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
- PMID: 32529545
- PMCID: PMC7289229
- DOI: 10.1007/s13659-020-00250-4
Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?
Abstract
New coronavirus referred to SARS-CoV-2 has caused a worldwide pandemic (COVID-19) declared by WHO. Coronavirus disease 2019 (COVID-19) is an infectious disease with severe acute respiratory syndrome caused by coronavirus-2 (SARS-CoV-2). SARS-CoV-2 is akin to SARS-CoV, which was the causative agent of severe acute respiratory syndrome (SARS) in 2002 as well as to that of Middle East respiratory syndrome (MERS) in 2012. SARS-CoV-2 has been revealed to belong to Coronaviridiae family as a member of β-coronaviruses. It has a positive-sense single-stranded RNA with the largest RNA genome. Since its genomic sequence has a notable similarity to that of SARS-CoV, antiviral drugs used to treat SARS and MERS are now being also applied for COVID-19 treatment. In order to combat SARS-CoV-2, many drug and vaccine development studies at experimental and clinical levels are currently conducted worldwide. In this sense, medicinal plants and the pure natural molecules isolated from plants have been reported to exhibit significant inhibitory antiviral activity against SARS-CoV and other types of coronaviruses. In the present review, plant extracts and natural molecules with the mentioned activity are discussed in order to give inspiration to researchers to take these molecules into consideration against SARS-CoV-2.
Keywords: Antiviral; Coronavirus; Medicinal plants; Natural products; SARS-CoV.
Conflict of interest statement
The authors declare no conflict of interest, financial, and otherwise.
Figures
Similar articles
-
Bioactive natural compounds against human coronaviruses: a review and perspective.Acta Pharm Sin B. 2020 Jul;10(7):1163-1174. doi: 10.1016/j.apsb.2020.06.002. Epub 2020 Jun 8. Acta Pharm Sin B. 2020. PMID: 32834947 Free PMC article. Review.
-
Plants-Derived Biomolecules as Potent Antiviral Phytomedicines: New Insights on Ethnobotanical Evidences against Coronaviruses.Plants (Basel). 2020 Sep 21;9(9):1244. doi: 10.3390/plants9091244. Plants (Basel). 2020. PMID: 32967179 Free PMC article. Review.
-
Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants.J Pharm Anal. 2020 Aug;10(4):313-319. doi: 10.1016/j.jpha.2020.03.009. Epub 2020 Mar 26. J Pharm Anal. 2020. PMID: 32296570 Free PMC article.
-
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.Curr Opin Pulm Med. 2014 May;20(3):233-41. doi: 10.1097/MCP.0000000000000046. Curr Opin Pulm Med. 2014. PMID: 24626235 Review.
-
Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.Am J Cancer Res. 2020 Aug 1;10(8):2535-2545. eCollection 2020. Am J Cancer Res. 2020. PMID: 32905393 Free PMC article.
Cited by
-
Biobran/MGN-3, an Arabinoxylan Rice Bran, Exerts Anti-COVID-19 Effects and Boosts Immunity in Human Subjects.Nutrients. 2024 Mar 19;16(6):881. doi: 10.3390/nu16060881. Nutrients. 2024. PMID: 38542792 Free PMC article.
-
Repurposing of Plant-based Antiviral Molecules for the Treatment of COVID-19.Curr Top Med Chem. 2024;24(7):614-633. doi: 10.2174/0115680266276749240206101847. Curr Top Med Chem. 2024. PMID: 38477206 Review.
-
In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease.Future Virol. 2023 Apr;18(5):295-308. doi: 10.2217/fvl-2022-0163. Epub 2023 May 22. Future Virol. 2023. PMID: 38052000 Free PMC article.
-
Identification of novel inhibitors from Urtica spp against TNBC targeting JAK2 receptor for breast cancer therapy.Med Oncol. 2023 Oct 8;40(11):326. doi: 10.1007/s12032-023-02193-5. Med Oncol. 2023. PMID: 37806999
-
Potential of amentoflavone with antiviral properties in COVID-19 treatment.Asian Biomed (Res Rev News). 2021 Aug 20;15(4):153-159. doi: 10.2478/abm-2021-0020. eCollection 2021 Aug. Asian Biomed (Res Rev News). 2021. PMID: 37551327 Free PMC article. Review.
References
-
- Groneberg D, Hilgenfeld R, Zabel P. Respir. Res. 2005;6:1–16. - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, Derisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ, Engl N. J. Med. 2003;348:1953–1966. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous